Table 1: Baseline Characteristics by Agent Received of Symptomatic Women with no Obstructive CAD.
Characteristics |
Adenosine (n=99) |
Regadenoson (n=40) |
p-value |
Age |
54 ± 11 |
53 ± 11 |
0.52 |
Body mass index |
29 ± 8 |
32 ± 7 |
0.01 |
Weight (kg) |
72 ± 16 |
81 ± 19 |
0.01 |
Ethnicity (% Caucasian) |
78 (79%) |
31 (78%) |
1 |
Diabetes |
8 (8%) |
6 (15%) |
0.23 |
Hypertension |
37 (37%) |
17 (43%) |
0.57 |
Current/former smokers |
43 (43%) |
19 (49%) |
0.70 |
Dyslipidemia |
8 (8%) |
6 (15%) |
0.23 |
Menopausal |
32 (32%) |
11 (28%) |
0.69 |
Hormone replacement therapy |
41 (41%) |
21 (53%) |
0.26 |
Ace-Inhibitor |
19 (20%) |
4 (11%) |
0.31 |
Angiotensin Receptor Blocker |
6 (6%) |
2 (5%) |
1 |
Beta-blocker |
24 (26%) |
11 (28%) |
0.83 |
Diuretic |
16 (16%) |
8 (21%) |
0.62 |
Birth Control Pill |
74 (76%) |
31 (82%) |
0.65 |
mean ± standard deviation, or n (%)